» Articles » PMID: 18395871

New Developments in Diagnosing and Treating Diabetic Foot Infections

Overview
Specialty Endocrinology
Date 2008 Apr 9
PMID 18395871
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Foot infections are common in persons with diabetes and are often the proximate cause of lower extremity amputation. There have been many publications in the past few years dealing with the appropriate ways to diagnose and treat diabetic foot infections. This review presents information gathered from a comprehensive, ongoing surveillance of the literature (published and abstracts) over the past 4 years. Prospective studies have now defined the epidemiology of diabetic foot infections, as well as methods to score and classify the wounds. Several recently published guidelines can assist clinicians in managing these infections. The etiologic agents of infection have been well-defined, and the prevalence of multi-drug-resistance pathogens is growing. Molecular methods offer great promise for quicker and more sensitive diagnosis of infection. New antimicrobial agents, both systemic and topical, as well as novel local treatments, have been shown to be effective in various studies. Improved methods of deploying older agents have added to the variety of treatment approaches now available. Several adjunctive treatments may benefit some patients but their role is as yet unclear. While there is much yet to learn about the most cost-effective ways to diagnose and treat diabetic foot infections the main effort is now to disseminate the available information and facilitate employing the evidence-based guideline recommendations.

Citing Articles

Bacteriological profile and antibiotic susceptibility of diabetic Foot infections at Ribat University hospital; a retrospective study from Sudan.

Hamid M, Arbab A, Yousef B J Diabetes Metab Disord. 2021; 19(2):1397-1406.

PMID: 33553032 PMC: 7843840. DOI: 10.1007/s40200-020-00660-8.


The Significant Association between Polymicrobial Diabetic Foot Infection and Its Severity and Outcomes.

Hitam S, Hassan S, Maning N Malays J Med Sci. 2019; 26(1):107-114.

PMID: 30914898 PMC: 6419864. DOI: 10.21315/mjms2019.26.1.10.


Pharmacokinetics and Tissue Penetration of Ceftolozane-Tazobactam in Diabetic Patients with Lower Limb Infections and Healthy Adult Volunteers.

Monogue M, Stainton S, Baummer-Carr A, Shepard A, Nugent J, Kuti J Antimicrob Agents Chemother. 2017; 61(12).

PMID: 28893779 PMC: 5700352. DOI: 10.1128/AAC.01449-17.


Prevention of lower-limb lesions and reduction of morbidity in diabetic patients.

do Amaral Junior A, do Amaral L, Bastos M, do Nascimento L, Alves M, de Andrade M Rev Bras Ortop. 2015; 49(5):482-7.

PMID: 26229849 PMC: 4487491. DOI: 10.1016/j.rboe.2014.06.001.


Microbiology of diabetic foot infections: from Louis Pasteur to 'crime scene investigation'.

Spichler A, Hurwitz B, Armstrong D, Lipsky B BMC Med. 2015; 13:2.

PMID: 25564342 PMC: 4286146. DOI: 10.1186/s12916-014-0232-0.